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ABSTRACT
Throughout embryonic development, blood vessels are derived from endothelial cells by
way of vasculogenesis. During angiogenesis, vessels remodel to form a hierarchy of
large-diameter arteries that branch into small-diameter capillaries. In this maturation,
vessels respond to unidentified signaling events to become surrounded with an outer layer
of vascular smooth muscle cells (vSMCs). This results in arteries that have a thick vSMC
layer, veins that have a thin vSMC layer, and capillaries that have a very thin or absent
vSMC layer. What remains to be determined is the cause of the thicker layer of vSMCs
around proximal arteries. Previous studies have implicated that mechanical forces
provided by blood flow control the growth of arteries over capillaries. I hypothesize that
these mechanical forces also determine the extent of vSMC coverage. To test this, I
compared the extent of vSMC in arteries of normal-flow mouse embryos (wild type) with
those in reduced-flow embryos (Myl7 [-/-] mutant). I observed less vSMC coverage in the
proximal arteries from reduced-flow embryos versus normal-flow embryos. With
immunostaining and confocal imaging, I determined that the amount of vSMCs did not
differ between reduced-flow and normal-flow tissues. Reduced-flow tissues exhibit a
failure of the vSMCs to migrate away from capillaries towards proximal arteries, and a
failure to surround the arteries. My findings provide evidence that hemodynamic force is
required for vSMC recruitment, but not for vSMC differentiation or proliferation.
KEYWORDS: Vascular smooth muscle cells, vessel maturation, vascular development,
angiogenesis, hemodynamic force
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INTRODUCTION

The cardiovascular system is comprised of a heart and blood vessels, and it is the
first functional organ system formed during embryonic development in mammals (Moore
and Metcalf, 1970), In the very early mammalian embryo, the cardiovascular system is
not required, as the embryo is small enough to rely upon simple molecular diffusion from
the surrounding maternal fluids/tissues. However, as the embryo grows, a functional
cardiovascular system is vital for the exchange of nutrients, gases, and waste products.
To set up this system, the embryo has the challenge of creating a hierarchical, branched
blood vessel tree, with large vessels connected to the heart, which connect to smaller
vessels far away from the heart. This is an important physiological adaptation for proper
oxygen exchange and for the efficient movement of blood. The establishment of this
complex vascular pattern is regulated by a series of cues that promote blood vessel
growth and development by several mechanisms: vasculogenesis, angiogenesis,
artery/vein specification, and vascular maturation.

Vasculogenesis
Vasculogenesis is the de novo development of new vessels from an aggregation of
endothelial cell precursors (angioblasts). Though the first blood vessels form during
vasculogenesis, this process can occur at various stages throughout an organism’s life.
Before vasculogenesis can occur, mesoderm tissue must form first, ultimately allowing
for angioblasts to emerge from a subset of the mesoderm. The mesoderm originates
during gastrulation when the primitive streak forms and elongates, and differentiating
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mesoderm cells ingress between the epiblast and primitive endoderm layers in a process
called epithelial-to-mesenchymal transition (EMT). This occurs at E6.0-6.5 (Embryonic
day—7 days after fertilization) in mice (Ichikawa et al., 2013). Upon EMT, epiblast cells
downregulate epithelial genes, such as E-cadherin, and upregulate other genes that gives
them the ability to migrate. Subsequently, they acquire mesenchymal markers such as Ncadherin (Ferrer-Vaquer et al., 2014). As cells from the epiblast migrate into the embryo,
all three germ layers of the mouse embryonic and extraembryonic tissue are present:
endoderm, mesoderm (embryonic and extraembryonic), and ectoderm (Kovacic et al.,
2012).
Vasculogenesis first starts in an extraembryonic tissue, called the yolk sac, where
blood vessels arise from a subset of extraembryonic mesoderm to give rise to primitive
yolk sac vessels E7.0 (Drake and Fleming 2000). Here, hemangioblasts
(blood/endothelial multipotent progenitor cells) arise from a subset of the extraembryonic
mesoderm. These cells collect together to form a structure called the “blood islands”.
Hemangioblasts of the blood islands then begin to differentiate into angioblasts
(endothelial cell precursors) and hematopoietic cells (blood cell precursors). Immediately
after, the angioblasts form tubes to encapsulate the hematopoietic cells, and these tubes
connect with other tubes to create the primitive capillary plexus of the yolk sac (Moore
and Metcalf, 1970) (Schmidt et al., 2007). The capillary plexus is a network of primitive
blood vessels that do not have any obvious hierarchies, as the capillaries are all
interconnected and have similar diameters. The formation of the capillary plexus relies
heavily on the activations of the Vascular Endothelial Growth Factor (VEGF) signaling
pathway (Ferguson et al., 2005). VEGF acts to regulate endothelial cell differentiation,
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migration, proliferation, and blood vessel branching patterns. Ultimately, VEGF
activation leads to the further differentiation of angioblasts into endothelial cells that now
express other endothelial markers (Pecam1, Tek, Laminin and Tal).
Slightly later (E7.3), the dorsal aortae (paired embryonic blood vessels) forms
from the connection of embryonic mesoderm-derived angioblasts to form a pair of
vessels that extend from the heart towards the posterior tail of the developing embryo
(Drake and Fleming, 2000). In the early embryo (E7.3), blood cell production exclusively
occurs in the yolk sac. By E7.8-E8.0, the yolk vessels connect to the heart, and the heart
connects to the dorsal aorta, and this connects back to the yolk sac vessels; thus forming a
circulatory loop.

Angiogenesis overview
The formation of new blood vessels from preexisting vessels is called
angiogenesis. This is accomplished through several different mechanisms, which also
leads to the development of blood vessel hierarchy. Angiogenesis occurs not only in
development, but during wound healing, hypoxia of tissues, and tumor growth in adult
tissues (D'Alessio et al., 2015).
During mouse development, angiogenesis begins at E8.5 in the newly formed
capillary plexus. Blood vessel formation occurs via four different mechanisms: sprouting,
fusion, intussusception, and regression. Sprouting is the most common mechanism used
during angiogenesis as well as in in adult tissues. A vessel can sprout from a pre-existing
vessel by a signal (VEGF) from the surrounding tissue. Specifically, an endothelial cell
of a blood vessel that is exposed to the highest amount of VEGF will become an
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endothelial tip cell. Tip cells are capable of growing/sprouting out of the vessel. Specified
tip cells then communicate to adjacent endothelial cells of the blood vessel via Dll4
(Delta like ligand 4)-induced Notch signaling. This provides two functions: 1) to
proliferate and provide more stalk cells behind the tip cells to grow out the sprout, and 2)
to downregulate the Vegf receptor so that the stalk cells do not become tip cells
themselves (D'Alessio et al., 2015). Another angiogenesis mechanism is blood vessel
fusion. Newly formed vessels will fuse to neighboring vessels. This can be done between
two parallel vessels to create a larger vessel (Udan et al., 2013a), and it could be done at
the tip of vessels to connect vessel sprouts together. It is known that macrophages aid in
blood vessel fusion by secreting VEGF-C to induce tip cell fusion (Tammela et al.,
2011). Regression is the pruning of blood vessels to eliminate supernumerary vessels, and
to refine vessel branching patterns. Notch/Dll4 signaling has also been shown to play an
important role in vessel regression (Korn and Augustin, 2015). The last known
mechanism of angiogenesis is intussusception, which is the angle change of blood
vessels. This form of angiogenesis is the least common, but has been detected in rodent
lung capillaries, and in chicken chorioallantoic vessels (Kurz et al., 2003).
Intussusception involves the formation of an endothelial pillar through the middle of a
vessel, and the expansion of that pillar, changing the angling of the vessel (Herbert and
Stainier, 2011).

Angiogenesis: vascular remodeling
All four mechanisms of angiogenesis play an important role in building new
vessels from preexisting vessels, but also in patterning the new vessels to create
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hierarchies and unique branching patterns. This later concept is named vascular
remodeling, which primarily acts by regulating vessels diameters to create the hierarchy.
Thus, vascular remodeling contributes to the formation of large-diameter arterial vessels,
which carry blood away from the heart, and large-diameter venous vessels, which carry
blood back towards the heart.
Hemodynamic force regulates vascular remodeling. For a decade, it has been
known that hemodynamic force (force that blood flow exerts on a blood vessel) acts as a
signal to promote the remodeling of the vasculature. For example, loss-of-function of the
Myosin light chain 7 (Myl7) gene, also known as Myosin light chain 2 (Mlc2a),
specifically impairs the ability of the atria of the heart to contract, leaving only the left
and right ventricles to pump blood (Huang et al., 2003). This produces a reduced bloodflow mouse embryo model (called reduced-flow) that results in a lack of vascular
remodeling (even though vessels do not express Myl7). Studies have confirmed that this
defect in remodeling was due to a lowering of hemodynamic force because experimental
removal of blood cells from circulation, in cultured embryos, lowers fluid viscosity. This
also reduces hemodynamic force, resulting in a lack of vascular remodeling (Lucitti et al.,
2007). However, if these same embryos are injected with hetastarch to increase plasma
viscosity, the vascular remodeling phenotype is recused, providing evidence that
hemodynamic force regulates remodeling. Moreover, subsequent studies have confirmed
that vessels exposed to high hemodynamic force undergo vessel-diameter increase by the
fusion of neighboring vessels together; whereas, vessels exposed to low hemodynamic
force remain as small-diameter capillaries (Lucitti et al., 2007); (Udan et al., 2013a). In
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summary, it is clear that hemodynamic forces play a crucial role in the development of
vessels.
Artery/venous specification. There are certain molecular markers that specify
endothelial cells to become endothelial vein or endothelial artery cells, but this varies by
location. In the mouse yolk sac plexus, EphrinB2 is involved in the determination of
arterial endothelial cells; whereas, EphB4 is involved in the determination of venous
endothelial cells (Shin et al., 2001). Also, Notch signaling (Delta-like ligand 4 and
Jagged2) helps specify arterial endothelial cells; whereas venous endothelial cells are
controlled by CoupTFII (You et al., 2005). In the intraembryonic tissue, artery and vein
genes are present but at different time points. Efnb2 and Notch related genes (Hey1,
Hey2, Dll4, Notch1 and Notch4) are expressed first in artery-fated endothelial cells and
then venous-fated endothelial cells (Corada et al., 2014).
Though arterial and venous markers become expressed prior to the onset of flow,
other evidence suggests that flow plays an important role in the maintenance of
arterial/venous gene expression. In chick embryos, the expression of EphrinB2 (arterial
marker) is dependent on flow and is not activated without the presence of blood flow (le
Noble et al., 2004). In the murine model, Neurophilin1 (Nrp1) plays a vital role in
capillary plexus patterning, but loss of flow downregulated EphrinB2, which is also
impacted by loss of Nrp1 (Jones et al., 2008).

Blood vessel maturation
Blood vessel maturation occurs after vessels remodel. This process occurs to
create a stable, mature vessel through the recruitment of mural cells to the recently
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remodeled endothelium layer. The term mural cell refers to both vascular smooth muscle
cells (vSMCs) and pericytes (Gaengel et al., 2009). Vascular smooth muscle cells
collectively wrap around large vessels as a tissue layer; whereas, pericytes are individual
cells that wrap around single capillaries.
In adults, vascular smooth muscle cells form a tissue layer called the tunica
media, which functions to regulate contractile tone, and hence blood flow in adult
vessels. The tunica media thickness varies in different tissues, which is dependent on the
function of that tissue. The arteries contain a very thick tunica media that helps to
counteract the strong pressure of oxygenated blood that is pumped throughout the entire
body. Veins contain the second thickest tunica media because the pressure of the
deoxygenated blood is reduced. However, capillaries have only a one-cell thick
endothelium, occasionally covered by single pericytes, or no tunica media at all (West,
2000). The reason for the reduction in vSMCs in capillaries is to enhance tissue
oxygenation. Lessons learned about embryonic vSMCs can likely still apply to adult
vSMCs because these cells are quite plastic and can detach from vessel walls, undergo
proliferation and migration, and reattach/redifferentiate into a stable form. This plasticity,
called phenotypic modulation, can occur in adult vessels upon injury, disease or growth
of new vessels (Jacot and Wong, 2008).
Since developing vessels are initially devoid of mural cells, understanding mural
cell origin may provide insight into their subsequent coverage of the endothelium. Mural
cells (vSMCs and pericytes) differentiate from various embryonic and extraembryonic
tissues, such as the neural crest, lateral plate mesoderm, and somatic/paraxial mesoderm
(Armulik et al., 2011). The main transcription factor that is required for the
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differentiation of mural cells from these tissues is serum response factor (SRF). However,
SRF is expressed ubiquitously throughout all cells during development, so there must be
other mechanisms to precisely control which cells become mural cells (Barron et al.,
2005). Factors that may provide tissue-specificity of mural cell differentiation are the
transcriptional coactivators of SRF: Myocardin, MRTF-A, and MRTF-B. These cofactors
are also required for vSMC differentiation, as loss of these genes in mice leads to in a
failure of vSMCs to differentiate, and overexpression of these cofactors in non-vSMCs
results in the induction of vSMC markers (Mack et al,. 2011). Myocardin, MRTF-A and
MRTF-B may allow SRF to function in a tissue-specific manner in a subset of mesoderm
and neural crest cells because MRTF-A and MRTF-B are highly expressed in vSMCs,
and Myocardin is detectable in vessels.
In the early yolk sac, when vessels are being remodeled (between E8.5 and
E9.25), the tissue is completely devoid of vSMCs, and by E9.5 the vSMCs arise from the
mesoderm, and quickly begin to surround the vessels. It is unclear how genes such as
Mrtf-A, Mrtf-B and Myocardin become upregulated in a subset of this mesoderm. Studies
have implicated Notch2, Notch3, Pdgf-β, and Tgf-β to act upstream of the transcriptional
coactivators to control their differentiation (Mack et al. 2011). However, whether these
same factors control vSMC coverage around vessels is unclear, because in addition to
controlling vSMC differentiation, they have also been shown to regulate vSMC
proliferation and recruitment. Therefore, it is unclear exactly how these factors influence
the cellular behaviors of vSMCs during the maturation process. Thus, more studies need
to be done to elucidate the role that vSMC differentiation, proliferation, or recruitment
play in vessel maturation.
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Even if Notch2, Notch3, Pdgf-B and Tgf-B regulate vascular coverage, it is
challenging to understand why only the large proximal vessels are capable of having the
highest vSMC coverage. Previous studies have implicated that every capillary of the yolk
sac that receives high-hemodynamic force is capable of forming the large proximal
vessel. This lends itself to the idea that hemodynamic force is also required for
determining the extent of vSMC coverage during maturation. Insight into the role of
hemodynamic force in regulating vSMC coverage may have important implications for
human health and disease, as there are many diseases associated with the thinning of
vessel walls.

Human significance
Improper thickness of vessel walls can lead to a variety of health problems in
humans, from a bulging of vessels known as a hemangioma or birthmark to congenital
brain aneurysms. Congenital vascular malformations (CVMs) occur in roughly 1% of all
live births in the United States and can affect arteries, veins, and lymphatic vessels in
children (Eerola et al., 2003). CVMs have many different forms of presentation, all with
varying impacts on health, which ranges to nearly unnoticeable to life threatening.
Arteriovenous fistula (or shunting) is the abnormal connection between veins and arteries
that can lead to swollen veins and arteries, decreased diastolic pressure, and an increased
burden on cardiac output (Liberthson et al., 1979). Children can be born with this
condition in a variety of places throughout their body, from the thoracic cavity to limbs.
Despite the frequent occurrence of these conditions, as of now, there is no explanation for
these phenomena (Jabari et al., 2016).
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Congenital arteriovenous aneurysms are rare but deadly when they occur in the
brain. Between 1939 and 2011, roughly 1200 cases of non-traumatic pediatric brain
aneurysms were reported (Sorteberg and Dahlberg, 2013). The causes of the aneurysms
are unknown, and many are unrelated to any disease. Hemorrhaging of the thinning
vessels usually occurs several years after birth. Many children have giant aneurysm
events when compared to adults, and their hemorrhaging events repeat throughout their
lifetime (van Rooij and Sluzewski, 2009). It has been reported that the mortality rate of
children with hemorrhaging events is as high as 50%. Follow-up studies and studies
discussing neurological functionality after an event are sparse due to many of the patients
in the initial study dying before completion of follow-up exaninations (Kakarla et al.,
2010).
Because of the variety of congenital vascular malformations and the reduced
lifespan of children born with them, it is important to understand the causes of these
CVMs. Many causes of CVMs are unknown and thus, treatments are reactive rather than
preventative. Development of treatments could include a drug to thicken vessel walls to
prevent repeated hemorrhaging events in congenital aneurysms patients.

Hypothesis and goals
My study begins to investigate whether hemodynamic force impacts the maturation of
blood vessels by affecting the coverage of vSMCs around large proximal vessels. As
previously stated, mouse embryos subjected to low hemodynamic force display impaired
vascular remodeling (Lucitti et al., 2007). In these embryos, proximal vessels fail to
undergo an expansion in diameter that is normally found at the top of the vessel
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hierarchy. In our preliminary studies, I sought to assess whether hemodynamic force
similarly affects vSMC coverage during maturation. I found that proximal arteries and
veins exhibited a high and medium level of vSMC coverage, respectively. This correlated
to differences in flow regimes in proximal arteries and veins, as previously published
(Udan et al., 2013b). Further, I also determined that reduction of hemodynamic force
resulted in diminished vSMC coverage in proximal vessels, resulting in a coverage
observed similar to that in distal capillaries of normal-flow embryos. Thus,
hemodynamic force must be controlling vSMC coverage, but the cellular mechanism for
this loss of coverage is unknown. I proposed two hypotheses to explain this loss of
coverage upon reduced hemodynamic force:
1. Hypothesis one: Hemodynamic force promotes the localized proliferation and/or
differentiation signals of vSMCs.
In this hypothesis, hemodynamic force may affect the number of vSMCs by
promoting the localized proliferation or differentiation of vSMCs around vessels
of high-flow. Here localized proliferation/differentiation would be followed by
immediate adhesion around the nearby vessels without much vSMC migration
(Fig. 1).
2. Hypothesis two: Hemodynamic force promotes the recruitment of vascular
smooth muscle cells.
In this hypothesis, hemodynamic force does not regulate the number of vSMCs.
Instead, it regulates the recruitment of vSMCs towards areas of high
hemodynamic force (Fig. 2).
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MATERIALS AND METHODS

Mouse care and lines
This study used animal subjects and prior approval for this project was obtained
from the Missouri State University Institutional Animal Care and Use Committee
(November 20, 2014; approval #15-004.0-A, December 01, 2014; approval #15-008.0A). Housing and procedures involving the mice met the requirements of National
Institute of Health animal care and use guidelines. Adult Myl7/Mlc2a (referred to as Myl7
in this study) (Huang et al., 2003) and Myl7;CD1-Tg(sma-mCherry) (Armstrong et al.,
2010) mice were bred in the animal vivarium. All mice were housed in Ancare standard
mouse cages at a temperature of 20.0-23.0 °C and under a diurnal cycle of 12-h light/ 12h dark, and had ad libitum access to water and Purina Labdiet 5001 (Purina) when not in
experimental use or Purina Formulab diet 5008 (Purina) when used for breeding and
experiments. Female and male mice used for experiments ranged 2-to-12 months in age.
Myl7/Mlc2a (Huang et al., 2003) and Myl7;CD1-Tg(sma-mCherry) (Armstrong et
al., 2010) embryos were used for immunohistochemistry whole yolk sac experiments.
Myl7 embryos and yolk sacs were used for flow cytometry experiments. Myl7;CD1Tg(sma-mCherry) embryos and yolk sacs were used for whole yolk sac
immunohistochemistry experiments. Determination of embryonic day was measured after
a noticeable vaginal plug present in the afternoon, marking that time point as E0.5.
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Whole yolk sac immunohistochemistry
Adult pregnant mice were euthanized in a plastic container via CO2 inhalation
followed by cervical dislocation. Whole embryos were isolated at E10.5 in cold
Phosphate Buffer Saline (PBS). The uterine muscle and decidua were removed to expose
the intact yolk sac. A small hole was cut into the top of the ectoplacental cone to ensure
exchange of buffer in and out of the yolk sac.
Embryos were fixed in 4% paraformaldehyde (PFA) in polypropylene roundbottom tubes while rotating on a nutator for 35 minutes. Embryos were washed 3 times
for 5-10 minutes each using PBS while shaking at room temperature. Then, the embryos
were given a final 5-10 minute wash using PBS containing 0.1% Triton (PBT) while
shaking at room temperature. Embryos were then washed in blocking buffer of 5%
Normal Donkey Serum (NDS; Sigma D9663-10mL), 1% Bovine Serum Albumin (GE
Healthcare Life Science SH30574.01) (BSA), in PBT for 1.5 hours at 4° C while shaking.
Embryos were then incubated for 48 hours in primary antibody with Serum Buffer Triton
(2.5% NDS in PBT) (SBT).
Primary antibodies used for these experiments and what they label are listed in
Table 1. Embryos were then washed several times in SBT over the course of one day to
be incubated in secondary antibody in SBT for 48 hours at 4° C while shaking. The
secondary antibodies used for these experiments and what they label are listed in Table 1.
Embryos were then washed in SBT 4 times by shaking at 4° C for 20 minutes, and the
last wash was done with PBS. The yolk sac was dissected open to display the arterial tree
on the right and venous vein on the left, and was mounted onto plain 3” x 1” x 1 mm
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microscope slides (Fisher Scientific 12-544-1). Slides were then imaged using confocal
microscopy. The embryos were saved for genotyping.

Quantification of vSMC total number and vSMC undergoing mitosis
Myl7;CD1-Tg(sma-mCherry) yolk sacs from E10.5 embryos were isolated,
stained with PH3 antibody or Kdr antibody and Sma antibody, and yolk sacs were flat
mounted on plain slides. Confocal images of endothelial, vascular smooth muscle, or
mitotic cells were taken using Olympus IX81-ZDC inverted fluorescence microscope
with the Slidebook 6.0 software. For area analysis of vSMCs in the distal capillary
regions, 5 Myl7 (+/+) & (-/-) yolk sacs and 4 Myl7 (-/-) yolk sacs were imaged. For area
analysis of mitotic cells and vSMC total, 7 Myl7 (+/+) & (+/-) yolk sacs were imaged and
4 Myl7 (-/-) yolk sacs were imaged. A random sample of 10 images (10 slices at 2.2 µm
for each image) were taken across different regions of each yolk sac using spinning disc
confocal EM-CCD digital camera, and a projection of the Z-stack was made to produce a
single image.
Quantification of the amount of vSMCs present in capillary regions of the yolk
sac was not possible because cell boundaries were not apparent. As a result, two or more
cells that overlap may appear as one cell. Thus, to quantify the amount of vSMCs that
occupy capillary regions, the percent area occupied by vSMCs divided by total surface
area was determined in reduced-flow yolk sac samples Myl7(-/-) and normal-flow yolk
sac samples Myl7(+/-). This was done by binarizing the image using Adobe Photoshop
so that all vSMCs were black and the background tissue was white. The percent area that
the vSMCs occupied was measured using ImageJ. Statistical analysis was done using a
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Student’s t-test in Microsoft Excel. For quantification of vSMC undergoing mitosis, PH3,
Sma double positive cells were quantified. These can be quantified as single cells, as the
PH3 labeling is distinct and does not overlap with other PH3-stained nuclei. These values
were then divided by the percent area occupied by the total vSMCs to give an estimate of
the amount of mitotic vSMCs in reduced-flow and normal-flow yolk sacs.

Flow cytometry/quantification of total cells and vSMCs
Total cell count and total vSMC count was analyzed using flow cytometry of
Myl7 (-/-) and Myl7 (+/-) embryo or yolk sac tissue. Whole embryos with yolk sacs were
isolated in cold Hank’s balanced salt solution with calcium chloride and magnesium
chloride (HBSS+) (Fisher Scientific) at E10.5 and the uterine muscle and decidua were
discarded. Both mutant and wild-type tissues were used and kept in 300 µL HBSS+,
separated based on phenotype. The embryos were separated from the yolk sac and saved
for analysis, the tails were cut to be used for genotyping. The tissue types used in this
experiment are listed in Table 2.
Cells were centrifuged at 300g for 30 seconds then media was replaced with Type
II 0.2% collagenase (Thermo Fisher Scientific, #17101015). Degradation of collagen was
done by incubating cells in 37°C incubator and by sequential pipetting with a pipette tips
of decreasing size (1000 µL, 200 µL, 10 µL) and finally with a 25 G x 38mm hypodermic
needle (Fisher Scientific, #14-826-49). Cells were filtered using a 40 µm cell strainer
(Fisherbrand), centrifuged at 300g for 10 minutes, after the removal of the medium and
fixed in 100 µL 2% PFA for 5-20 minutes (depending on experiment) on ice. Cells were
centrifuged at 300g for 10 minutes, media removed, then incubated in 100 µL 1x
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Permwash (Biolegend) and 2.5% NDS for 10 minutes on ice. Then, cells were
centrifuged at 300g for 10 minutes, after the removal of the medium, the cell pellet was
resuspended in 100 µL 1x Permwash (with or without 1:200 SmaCy3 antibody), and
incubated for 15 minutes at room temperature. For flow cytometry analysis, cells were
centrifuged at 300g for 10 minutes then placed in 100 µL 1x Permwash and quantified in
a BD Accuri C6 Flow Cytometer. Samples were run through on unlimited events, for a
maximum of 1,000,000 events that included forward side scatter over 10,000.
Parameters on the C6 software were chosen based on repeated trials of control
autofluorescence yolk sacs and embryos without the Sma-Cy3 antibody as compared to
fluorescence of samples with the Sma-Cy3 antibody. This allowed for comparison of the
cells natural fluorescence with the fluorescence that occurs upon addition of the Sma-Cy3
antibody. Cells with background fluorescence were removed from counts by selecting the
forward scatter gate of registering events that fluoresce at 104 or higher.

Tail cuts/DNA isolation
Juvenile and adult mice had tail cuts performed for genotyping. Juvenile tail cuts
were performed without anesthesia and used for DNA isolation. Adult mouse tail cuts
were performed with 3ppm isoflurane until mice were unconscious, then tails were
clipped. 200 µL of tail buffer (1 mL of 5M NaCl, 2.5 mL of 1M Tris pH 8.0, 10 mL of
0.5M EDTA pH8.0, 5 mL of 10% SDS, q.s. 50 mL) was added to the tail clip with 10 µL
Proteinase K (Thermo Scientific) and incubated for 24 hours at 55°C. The solution was
briefly mixed by flicking the tube to finalize resuspended tissue and 200 µL of phenol
chloroform was added. The tubes were then gently mixed by shaking up and down 20-30
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times and centrifuged for 10 minutes at 13.3 g at room temperature. Subsequently, the
aqueous phase was transferred to a clean microcentrifuge tube, and the organic phase was
discarded. An equal amount of 100% isopropanol was added, mixed, and then
centrifuged at 13.3g for 10 mins. The solution was removed by decanting, the pellet was
washed in 500 µL of 70% ethanol, and centrifuged at 13.3 g for 10 minutes. The ethanol
was decanted and the tubes were left to dry upside down on a tissue. The DNA was
suspended in 75 µL of distilled water was 24 hours at 4°C.

PCR genotyping
DNA extracted from embryonic tails were used for genotyping to validate
phenotypic expression. Purified embryonic DNA was amplified using Pro-Taq DNA
polymerase (Deville Scientific, Inc) and the following primers (5’ – 3’): wild-type band,
Myl7-wt-F (GGCACGATCACTC) and Myl7-wt-R (ATCCCTGTTCTGG); mutant band,
Myl7-mut-F (ACAGGGAATCACA) and Myl7-mut-R (CGAACCTGGTCGA). PCR
cycles consisted of denaturing at 95.0°C for 5 minutes, then 35 cycles of denaturing at
95.0°C 30 seconds, annealing at 56.5°C 30 seconds, and extension at 72.0°C 1 minutes,
and a final extension at 72.0°C for 5 minutes.
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Table 1. Antibodies used in my study.
Antibody

Experimental
Procedure
Whole Yolk
Sac (both)

Dilution

Company

1:200

Abcam

Incubation
Period
48 hours

Anti-alpha
smooth muscle
actin-Cy3,
made in mouse

Whole Yolk
Sac (both),
Flow
Cytometry

1:1250, 1:250

Sigma Sciences

48 hours

Anti-histone
H3, made in
rabbit

Whole Yolk
Sac (Mitosis
count)

1:500

Abcam

24 hours

DAPI, made in
mouse

Whole Yolk
Sac (vSMC
count)

1:500

Sigma Sciences

48 hours

Alexa Fluor
488 donkey
anti-goat

Whole Yolk
Sac (vSMC
count)

1:500

Life
Technologies

48 hours

Alexa 568
donkey antirabbit

Whole Yolk
Sac (mitosis
count)

1:500

Life
Technologies

24 hours

Alexa Fluor
488 donkey
anti-rabbit

Whole Yolk
Sac (mitosis
count)

1:500

Life
Technologies

48 hours

Anti-vascular
endothelial
growth receptor
2, made in goat
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Table 2. Tissues used in quantification of total cells and vSCMs
Tissue Type

Amount

Genotype

Antibody

Embryo

1

Wild-type

None

Yolk Sac

2

Wild-type

None

Embryo

1

Mutant

None

Yolk Sac

2

Mutant

None

Embryo

1

Wild-type

Anti-alpha smooth
muscle actin-Cy3

Yolk Sac

2

Wild-type

Anti-alpha smooth
muscle actin-Cy3

Embryo

1

Mutant

Anti-alpha smooth
muscle actin-Cy3

Yolk Sac

2

Mutant

Anti-alpha smooth
muscle actin-Cy3
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PRELIMINARY DATA

vSMC coverage is reduced in yolk sac vein and capillaries compared to artery
As mentioned above, adult blood vessels exhibit a difference in vSMC coverage
between arteries, veins, and capillaries, with arteries having highest vSMC coverage.
Since I are interested in understanding what controls vSMC coverage, I sought to
determine if the same difference in thickness is apparent during embryonic development.
Yolk sacs from E10.5 embryos were used, as the vasculature is well developed and
vessels have matured. For example, the arterial tree exhibits regular branching into
smaller primary and secondary branches; the vitelline vein displays two main vessels; and
the capillary region connects the arteries and veins. These vessels have already initiated
maturation only one day earlier (at E9.5), and by E10.5 stable, mature blood vessels have
formed.
To observe if there was a vSMC coverage difference between yolk sac arteries,
veins, and capillaries, whole-mount immunostaining and confocal microscopy was used.
The proximal artery showed complete vSMC coverage around the inner lining of the
vessel— comprised of endothelial cells (Fig. 3A-C). In comparison, the vein showed
vSMC coverage around the vessel, however, the fluorescence signal was not as strong as
in the artery (Fig. 3D-F). Also, vSMC coverage was the most dramatically reduced in the
capillary region of the mouse yolk sac (Fig. 3G-I). These data reveal that the extent of
vSMC coverage is similar to what is observed in the adult, even at this very early stage of
maturation.
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Interestingly, the amount of vSMC coverage correlated to the levels of
hemodynamic force, as previously measured in proximal arteries, veins, and capillaries of
yolk sacs (Udan et al. 2013). Considering that hemodynamic force has been shown to
regulate vessel hierarchy, I sought to determine if hemodynamic force is similarly
required for controlling the amount of vSMC coverage.

Vascular smooth muscle layer is reduced with low hemodynamic force in the yolk
sac proximal artery and the dorsal aorta
To determine whether hemodynamic force impacts the maturation of blood
vessels, I analyzed vSMC coverage in Myl7 reduced-flow mutant (-/-) and normal-flow
control (+/-) embryonic yolk sacs. The yolk sac vasculature in normal-flow arteries
displayed a large diameter vessel comprised of endothelial cells and a complete coverage
of vSMCs (Fig. 4A-C). However, the proximal artery of the yolk sac in reduced-flow
embryos showed poor vessel development, and minimal vSMC coverage of the vessel
(Fig. 4D-F).
Next, I sought to determine if this phenotype was similarly found in
intraembryonic vessels. Though the capillary network is still growing in E10.5, the most
prominent vessel of the embryo, the dorsal aorta, is functional. The challenge to imaging
these vessels is that it is internal, thus, it could not be imaged by a whole-mount
approach, due to light scattering issues, thus, I performed cross sections. E10.5 normalflow dorsal aorta cross sections showed robust vessel development of the endothelial
cells and complete vSMC coverage around the vessel (Fig. 4G-I). Similar as the reducedflow yolk sac vasculature, the reduced-flow dorsal aorta also exhibited reduced vessel
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development and almost no vSMC coverage around the vessel (Fig. 4J-L). These results
reveal that reduction of hemodynamic force does not impact blood vessel formation, but
does impact its maturation.
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RESULTS

Low Hemodynamic Force does not impact the Proliferation and Differentiation of
vSMCs
It is clearly evident that hemodynamic force regulates that amount of vSMCs that
surround the yolk sac and embryonic arteries, and I similarly saw this disparity in
reduced-flow proximal veins (data not shown). To explain this phenotype, two
hypotheses were formulated: 1) hemodynamic force regulates the localized
proliferation/differentiation of vSMCs (which later surround the closest vessels), 2)
hemodynamic force regulates the recruitment of vSMCs to the high-flow, proximal
vessels (without affect the differentiation/proliferation status of the cells) (Fig. 1).
To determine whether vSMC proliferation was influenced by reduction of
hemodynamic force, I stained normal-flow and reduced-flow yolk sac tissue with a
mitotic antibody marker (phospho-Histone H3 [PH3]) and co-labeled with a vSMC
antibody marker (Smooth muscle alpha actin [Sma]). PH3 cells were easily identified and
counted: however, vSMCs could be visualized, this was a cytoplasmic marker. It was
difficult to determine whether two vSMCs that were adhered together where separate
cells or the same cell. Thus, I quantified total PH3-labeled cells and divide this number
by the total surface area occupied by vSMC staining to determine a mitotic index. After
comparing the mitotic index in normal-flow vs. reduced-flow embryonic yolk sacs, I
observed no difference in proliferation—suggesting that hemodynamic force does not
affect the proliferation status of vSMCs (Fig. 5I).
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Though this data indicates that hemodynamic force does not impact global levels
of proliferation, perhaps it affects the ability for vSMCs to differentiate. One strategy to
determine whether there is an altered differentiation status is to assess changes in vSMC
differentiation markers. Thus, I sought to determine if expression of the vSMC
differentiation marker, Mkl2 (Mokalled et al., 2015), was altered upon reduced-flow.
However, qRT-PCR of Mkl2 in normal-flow versus reduced flow E10.5 yolk sacs
revealed no significant difference in global expression patterns of Mkl2 (data not shown).
One caveat to this experiment is that there could be minute differences in gene expression
that are not detectable by qRT-PCR, but perhaps reduced-flow yolk sacs still exhibit
diminished vSMC differentiation. In this case, flow could still impact the total number of
vSMCs available to cover vessels.

Hemodynamic force does not impact the total number of vSMCs available
Since there could still be undetectable differences in vSMC differentiation, this
could affect the total amount of vSMCs available to cover vessels, even if the vSMC
proliferation rates are the same. For example, if one tissue starts off with 8 vSMCs, and
another with 10 vSMCs, if all parent and daughter cells divide three times, the first tissue
will have ~ 512 vSMCs, and the second would have 1000 vSMCs—nearly double the
amount. Thus, I wanted to determine if reduced-flow embryos and yolk sacs have a lower
total amount of vSMCs than in normal-flow yolk sacs. Using microscopy, it is impossible
to visually quantify the total number of vSMCs because of the overlap around proximal
arteries and veins. Thus, to measure if there was a total change of vSMC affected by low
hemodynamic force, flow cytometry with the Sma antibody was used (Fig. 1).
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Measurements were taken by counting the total number of vSMCs (Sma+ cells) divided
by the total number of embryo or yolk sac cells that flow through the cytometer. This
allows for accurate comparisons between tissues that may not be the exact same size.
Normal-flow and reduced-flow tissue from whole embryos were compared and no
significant difference in the amount of vSMCs was observed (Fig, 6). Similarly, no
significant difference in the total amount of vSMCs was found when comparing yolk sac
tissue (Fig. 6). In summary, hemodynamic force does not impact the total number of
vSMCs available for vessel coverage. I reasoned, therefore, that a factor other than
hemodynamic force explain why reduced-flow vessels fail to acquire a vSMC layer.

Hemodynamic force affects the recruitment of vSMCs from capillary region to
proximal vessels
Based on my observations that hemodynamic force did not impact the total
number of vSMCs available, I speculated that hemodynamic force did not affect the
ability for vSMCs to differentiate from the mesoderm, or to exhibited altered
proliferation. Instead, vSMCs failed to be recruited from the surrounding capillary region
towards the proximal arteries and veins (Fig. 2). To assess if recruitment is impaired by
reduced-flow, Myl7;CD1-Tg(sma-mCherry) with Sma-myr::mCherry transgenic mouse
yolk sac were used to assess an area analysis of the space occupied by vSMC in the
capillary regions. The premise behind this analysis is that in normal-flow yolks sacs,
vSMCs differentiate and proliferate normally in the capillary regions, and they migrate
towards the larger, high-flow proximal vessels. In reduced-flow, on the other hand, I
speculate that the cells do not migrate to the proximal vessels (because they have low-
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flow). As a result, I anticipate visualizing more vSMCs in the capillary regions of
reduced-flow yolk sacs.
Capillary regions of normal-flow yolk sacs showed that there were vSMCs
present (Fig. 7A-D). However, in the capillary regions of reduced-flow yolk sacs, there
was an increase in the amount of vSMCs present (Fig. 7E-H). After binarization and area
analysis, there was a significant increase in the amount of area occupied by vSMCs in
low hemodynamic force capillary regions relative to the normal flow capillary regions
(Fig. 7I). Thus, this suggests that hemodynamic force promotes the recruitment of
vSMCs to vessels of high-flow.
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DISCUSSION

Adult vessels that are located closer to the heart (proximally) have a thicker tunica
media layer relative to vessels closer to the extremities (distally) (Isayama et al., 2013).
Vessels closer to the heart are subjective to much stronger hemodynamic forces and must
have a thicker vascular smooth muscle layer to counteract those forces. Data produced by
this study supports that differences in tunica media thickness are established during
embryonic development, and that hemodynamic force is the key regulator for vSMC
coverage. Results demonstrate that the cellular mechanism of hemodynamic forceinduced vascular maturation involves the recruitment of vSMCs from the capillary
regions towards the proximal arteries and veins, and this does not occur by a localized
vSMC proliferation/differentiation mechanism.
In normal-flow mouse embryos, our results revealed noticeable differences in
vSMC coverage in different vessel subtypes, with highest coverage in proximal arteries,
followed by a progressively reduced coverage in proximal veins and capillaries. This
reduction is likely due to the differences during development in the amount of
hemodynamic force that the developing vessels are exposed to. For example, proximal
arteries in the mouse yolk sac are subjected to the strongest forces, as blood leaving the
embryo enters into the yolk sac (McGrath et al., 2003); (Udan et al., 2013). Upon the
distribution of the blood into numerous capillaries, hemodynamic force diminishes. As
blood collects in the proximal vein is carried blood away from the yolk sac back to the
embryonic heart, the hemodynamic force increases but will not the level found in
proximal arteries. These differences in force correlate well with differences in vSMC
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coverage, implicating that extent of hemodynamic force determines the amount of vSMC
coverage. Indeed, hemodynamic force is required for proper maturation, as our data in
reduced-flow embryos reveals diminished or an absent vSMC coverage, even around
proximal arteries.
Given the correlation of the amount of force and the extent of vSMC coverage, I
propose a model where hemodynamic force acts like an analog signal, rather than a
digital signal. Thus, force induces a gradient of recruitment signaling of vSMCs, as
oppose to an on-and-off signaling mechanism. The wide variety in thickness of tunica
media lends support to this model. There is no set amount of thickness for a given vessel
and there is a variation throughout an organism (Dinardo et al., 2014).
A recently published study reached a similar conclusion, and proposed that
hemodynamic force regulated mural cell coverage in blood vessels (Chen et al., 2017).
Using zebrafish embryos, the Santoro lab proposed a mechanism where blood vessel
endothelial cells possess non-motile cilia that deflect upon exposure to hemodynamic
force. This, in turn upregulates Notch and Foxc1b expression to encourage mural cell
recruitment. Based on evidence that our lab and others have collected, it appears as if
there is partial conservation of this pathway in the mouse. What is not conserved is the
role of non-motile cilia. These cilia are not detected in mouse yolk sac vessels (personal
communication with Mary Dickinson, Baylor College of Medicine). What does appear to
be conserved is the Notch pathway, which I have observed is downregulated in reducedflow mouse embryos (data not shown). However, more studies need to be done to
validate the role of Notch in vSMC recruitment, and to determine the role of the FoxC1
gene in vascular maturation of the mouse. Though the Santoro lab has provided insight
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into the molecular mechanisms of vSMC coverage, the investigators did not assess
whether increased coverage occurs via vSMC recruitment or localized vSMC
proliferation/differentiation.
The mechanism of how high-flow, proximal vessels signal the recruitment of
vSMCs remains unknown. One possible mechanism is that high-flow vessels recruit
vSMCs via chemotaxis towards a paracrine factor. For example, vessels that are exposed
to high hemodynamic force could induce Notch activation. This, in turn, could upregulate
expression of a paracrine factor, and vSMCs will migrate in the direction towards the
highest concentration of the paracrine factor. In another possible mechanism, maturation
occurs via a juxtacrine pathway. Perhaps, vSMCs randomly migrate throughout the yolk
sac, but they only adhere to vessels that express adhesion factors, like cadherins or gap
junction molecules. In this scenario, vSMCs only adhere to high-flow vessels which
express a high amount of adhesion molecules.
To determine which mechanism occurs, live imaging and cell tracking studies will
be performed. However, it is challenging to visualize vSMC recruitment over time in
mice. vSMCs differentiate at around E9.5, and the culturing mouse embryos beyond this
point is challenging. Thus, in future studies, confocal imaging will be performed using
E9.5 embryos that will be cultured only for several hours (instead of overnight). Though
several problems need to be overcome (setting up the confocal for live embryo culture,
determining whether excitation light will allow for visualization but will not
photodamage the embryo, and ensuring that the culturing time is sufficient to visualize
migration), the ultimate goal will be to visualize if vSMCs stream towards proximal
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vessels, or if they undergo random migration, but stick to the proximal vessel when
nearby.
Though the studies of this thesis represent basic science, my findings could have
significant applicability for human health and medicine. By ultimately discovering the
mechanism for vSMC recruitment, this information could be used to control vSMC
recruitment in adult vessels that are depleted of the tunica media (perhaps caused by a
congenital defect, injury, or environmental factors). For example, aneurysms are regions
of a blood vessel that have a weak vessel wall, partly caused by the degradation of the
tunica media that are prone to ballooning and potentially hemorrhaging. Currently, stents
are used to repair cardiovascular aneurysms, however, many patients experience repeated
aneurysm events, leading to a reduced lifespan (Lederle et al., 2012). Since stents can be
used to deliver localized treatment by seeding with a drug (Giap, 2002), stents could be
seeded with discovered factors to encourage vSMCs to be recruited to the thin vessel
walls. It is possible that adult vSMCs will respond in a way similar to the embryonic
vSMCs response, because they are capable of reverting to an embryonic-like vSMC (a
process called phenotypic modulation) where they are capable of partial dedifferentiation,
proliferation, migration, and redifferentiation (Rensen et al., 2007). In summary, results
from my basic science research could point in the direction of possible clinical advances.
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Figure 1. Hypothesis 1: Hemodynamic force promotes the localized proliferation and/or
differentiation of vSMCs. In normal-flow yolk sacs, areas of high hemodynamic force,
including the proximal arteries and veins, secrete differentiation and/or proliferation
signals to promote the localized differentiation and/or proliferation of vSMCs; whereas,
the distal capillaries with low hemodynamic force would have fewer vSMCs. In this
model, vSMCs are limited in the ability to migrate around the yolk sac, so they wrap
around the nearest vessels, resulting in a higher amount in proximal vessels. If
hemodynamic force is reduced throughout the entire yolk sac, the expected phenotype
would be a reduction in vSMCs in proximal vessels, as well as a reduction in the distal
capillaries. Figure modified from Udan et al., 2013a.
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Figure 2. Hypothesis 2: Hemodynamic force promotes the recruitment of vSMCs. In
normal-flow yolk sacs, vSMCs are capable of differentiating evenly throughout the entire
yolk sac. However, proximal vessels with higher hemodynamic force promote the
recruitment of vSMCs from distal capillaries with lower hemodynamic force. If
hemodynamic force is reduced throughout the entire yolk sac, there will be an absence of
recruitment signals, but there will be no change in the overall amount of vSMCs
available. Thus, the expected phenotype would be the appearance of a greater amount of
unbound vSMCs (vSMCs that fail to recruit and surround vessels) in distal capillary
regions. Figure modified from Udan et al., 2013a.
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Figure 3. Proximal arteries exhibit greater vSMC coverage than proximal veins and distal
capillaries. Whole mount embryonic mouse yolk sacs were labeled with endothelial cell
(Kdr/Flk1:Alexa Fluor488) and vSMC cell (Sma-myr::mCherry) markers to display the
proximal artery, proximal vein, and distal capillaries in a normal-flow yolk sac. The
artery shows complete vSMC coverage around the vessel, which is comprised on
endothelial cells (A-C). In comparison, the vein shows vSMC coverage around the
vessel, however, vSMC coverage is sparse when compared to the artery (D-F). The
capillary region of the yolk sac (G-I) shows the most significant reduced coverage, as
only individual vSMCs are found around the endothelium.
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Figure 4. Vascular smooth muscle layer is reduced in low hemodynamic force.
Embryonic whole mount yolk sac and dorsal aorta cross section tissue were labeled with
endothelial cell (Kdr/Flk1:Alexa Fluor488) and vSMC cell (Sma-myr::mCherry)
markers. vSMC coverage is reduced in Myl7 (-/-) reduced-flow proximal arteries (D-F)
when compared to Myl7 (+/-) normal-flow proximal arteries (A-C). This was also
observed in intraembryonic tissues, as the cross sections of the dorsal aorta of normalflow embryos displayed high vSMC coverage (G-I); whereas, the dorsal aorta of reducedflow embryos exhibited diminished/absent vSMC coverage (J-L).
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Figure 5. Low hemodynamic force does not impact the proliferation and differentiation of
vSMCs. Representative images of E10.5 Myl7 wild-type (normal-flow) yolk sacs (A-D)
and Myl7 mutant (reduced-flow) yolk sacs (E-H). Yolk sacs were labeled with phoshohistone H3 (PH3) and Alexa Fluor488 antibodies (mitotic marker) and Smamyr::mCherry (Sma) smooth muscle marker. The total number of PH3, Sma double
positive cells were divided by the total surface area occupied by Sma-labeled cells to
develop the mitotic index. Comparison of the mitotic index between the normal-flow and
reduced-flow yolk sacs reveal no significant difference (I). Statistical significance was
calculated using standard error, p <0.05.
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Figure 6. Total number of vSMCs is not impacted by low hemodynamic force. Flow
cytometry analysis, using the Sma-myr::mCherry smooth muscle marker to label vSMCs,
revealed that the total number of vSMCs is not significantly different between normalflow or reduced-flow embryonic or yolk sac tissue. Statistical significance was calculated
using standard error, p <0.05.
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Figure 7. Recruitment of vSMCs from capillary region is impaired in low hemodynamic
force yolk sacs. Representative images of distal capillary regions of Myl7 wild-type
(normal-flow) yolk sacs (A-D) and Myl7 mutant (reduced-flow) yolk sacs (E-H). Yolk
sacs were labeled with Kdr/Flk1:Alexa Fluor488 endothelial marker and Smamyr::mCherry smooth muscle marker. Myl7 mutant yolk sacs displayed significantly
(P<0.001) increased vSMC area coverage when compared to Myl7 wild-type capillary
regions (I).
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